EuroPCR 2012 - Paris
Grupo CARDIOnef tuvo el placer de atenderle en el EuroPCR 2012 como representante de México para la compañía HEXACATH el cuál se efectuó en

Paris, Francia, ahí estuvimos dando a conocer los últimos e innovadores avances en la tecnología médica Hexacath, además de sus ventajas y beneficios hacia los pacientes en su línea de productos como: Stent TITAN2,

Cateter Balón Rafale, Catéter para aspiración RECOVER, Stents periféricos Helios y Heliflex.









Descargas - euroPCR 2012


  • Introducing Titan Optimax
  • Complete Information about Titan Optimax (242.3 Mb)
  • Summary of TiTAN2 vs Xience/Taxus 18 & 36 months
  • Brouchure Heliflex (4.3 Mb)
  • Brouchure Recover (3.5 Mb)
  • Brouchure Mistral (3.4Mb)
  • Raber Study (1 Mb)

  • exposiciones - euroPCR 2012 Hexacath

    Understanding the complex pathology of ACS patients... / Renu Virmani, MD 

    Understanding the complex pathology of ACS patients & the best possible stent treatments available Renu Virmani, MD

      Virmani-20120517-1205-Room342A

     

    TAKE HOME MESSAGE 

    Titanium Nitride Oxide is one of the technologies (not eluting drug) lowering Late Loss significantly versus BMS without putting the patients at risks of negative late loss. • 1st generation DES (mainly the Cypher) with Late Loss between 0 to 0.2 mm leads to a proportion of the DEStreated population with negative late loss, delayed healing, AMI, thrombosis, death and of course prolonged DAPT.

      Serruys-20120517-1320-Room342A

     

    Titanium Nitride Oxide Active Stent / Combining DES 

    Titanium Nitride Oxide Active Stent: Combining DES Clinical Efficacy with Enhanced BMS Safety CHAIRPERSONS: Renu Virmani, Patrick Serruys

      Serruys-20120517-1200-Room342A

     

    24 months Follow-up results / Pasi Karjalainen, MD, PhD, adjunct Professor 

    The BASE-ACS Trial A Randomized Comparison of a TITAN-2 BAS with XIENCE-VEES Stent in Acute Coronary Syndrome 24 months Follow-up results Pasi Karjalainen, MD, PhD, adjunct Professor

      Karjalainen-20120517-1235-Room342A

     

    Lad Bifurcation with septal and diagonal / Dr. Flavio Tarantino 

    Lad Bifurcation with septal and diagonal Dr. Flavio Tarantino

      HWIT Tarantino-20120516-1250-Room242B

     

    Stemi with proximal Lad Occlusion / Dr. Flabio Tarantino 

    Stemi with proximal Lad Occlusion Dr. Flabio Tarantino

      HWIT Tarantino-20120516-1210-Room242B

     

    Bifurcation LAD lesion in NSTEMI How would I treat? / Prof. Morris Mosseri 

    Bifurcation LAD lesion in NSTEMI How would I treat? Prof. Morris Mosseri Meir Medical Center, Israel

      HWIT Mosseri-20120516-1255-Room242B

     

    STEMI Case How would I treat? / Prof. Morris Mosseri 

    STEMI Case How would I treat? Prof. Morris Mosseri Meir Medical Center, Israel

      HWIT Mosseri-20120516-1215-Room242B


    NSTEMI Case : How did I treat / Fina Mauri, MD, PhD 

    NSTEMI Case : How did I treat Fina Mauri, MD, PhD

      HDIT Mauri-20120516-1300-Room242B

     

    STEMI Case : How did I treat ? / Gilles Grollier, MD, PhD 

    STEMI Case : How did I treat ? Gilles Grollier, MD, PhD

      HDIT Grollier-20120516-1220-Room242B

     

    Popliteal Artery Angioplasty / Yann Goueffic, MD, PhD 

    Popliteal Artery Angioplasty The Vascular Surgeon's Approach HOW DID I TREAT ? Yann Goueffic, MD, PhD

      Goueffic-20120517-1730-Room353

     

    Popliteal Artery Angioplasty / Yann Goueffic, MD, PhD 

    Popliteal Artery Angioplasty The Vascular Surgeon's Approach Yann Goueffic, MD, PhD

      Goueffic-20120517-1715-Room353


    Lessons from comparative trials / Adam de Belder, MD 

    Lessons from comparative trials in ACS assessing patients outcomes after various stenting options Adam de Belder, MD

      deBelder-20120517-1250-Room342A

     

    Superficial Femoral Artery Angioplasty / Maher Dabboussi, MD 

    Superficial Femoral Artery Angioplasty The Vascular Surgeon’s Approach HOW WOULD I TREAT ? Maher Dabboussi, MD

      Dabboussi-20120517-1645-Room353

     

    Popliteal Artery Angioplasty / Angelo Cioppa, MD 

    Popliteal Artery Angioplasty The Cardiologists's Approach HOW SHOULD I TREAT ? Angelo Cioppa, MD

      Cioppa-20120517-1725-Room353


    Superficial Femoral Artery Angioplasty / Angelo Cioppa, MD 

    Superficial Femoral Artery Angioplasty The Cardiologist’s Approach HOW DID I TREAT ? Angelo Cioppa, MD

      Cioppa-20120517-1650-Room353

     

    Superficial Femoral Artery Angioplasty... 

    Case Presentation: Superficial Femoral Artery Angioplasty The Cardiologist’s Approach Angelo Cioppa, MD

      Cioppa-20120517-1635-Room353

     

    Clinical History / 48 years old man 

    Fina Mauri, MD, PhD Hospital Universitari Germans Trias i Pujol Badalona, Spain

      Clinical History

     

    Clinical History / 43 year-old woman 

    Medical treatment • Aspirin 250 mg (IV) • Clopidogrel 600 mg (NG tube) • Standard Heparin 6000 UI (IV)

      Clinical History

     

    The Evidence on First and Second Generation Nitinol Stents 

    Titanium-Nitride Oxide Bio Active Coated Stents for SFA & Popliteal applications: Sharing the Experience between Surgeons, Angiologists & Cardiologists G. Biamino, MD, PhD

      Biamino-20120517-1630-Room35

     

    euroPCR Hexacath 

    How to deal with a complex ACS patient associated with a large thrombus burden ? Michael Angioi, MD, PhD

      Angioi-20120517-1220-Room342A